Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Cannabis Regulatory Commission approves reports, licenses and multiple enforcement actions
Summary
The New Jersey Cannabis Regulatory Commission at its June 12 meeting approved the 2024 annual report, adopted social-equity excise fee recommendations, cleared dozens of license actions (conversions, annuals, renewals and ownership transfers) and voted to impose enforcement penalties on four licensees, including a temporary suspension posture for Columbia Care.
The Cannabis Regulatory Commission met June 12 and approved a slate of administrative and enforcement items spanning licensing, reports and sanctions.
The board adopted the 2024 annual report and approved routine agenda items including approval of minutes, 4 conditional-to-annual conversions, 9 annual licenses, 10 annual renewals and six ownership-transfer requests. Director Chris Riggs told commissioners that the licensing office has approved roughly 2,300 applications and that about 355 operating licenses and permits were active across New Jersey; the medicinal program had about 60,000 enrolled patients as of mid-May 2025.
On the commission's mandated social equity excise fee recommendations, the board voted to adopt the Public Engagement and Education Committee's report endorsing revenue uses such as grants and low-interest loans for diversely owned and social-equity businesses, workforce development,…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
